Viewing Study NCT03052205


Ignite Creation Date: 2025-12-25 @ 3:33 AM
Ignite Modification Date: 2026-05-10 @ 7:39 AM
Study NCT ID: NCT03052205
Status: COMPLETED
Last Update Posted: 2020-02-11
First Post: 2017-02-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Sponsor: Idera Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Solid Tumors View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ILLUMINATE-101 View
None melanoma View